Electromedical Technologies, Inc. (EMED)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Mar 17, 2025, 9:41 AM EST

EMED Statistics

Total Valuation

EMED has a market cap or net worth of 186,005. The enterprise value is 2.58 million.

Market Cap 186,005
Enterprise Value 2.58M

Important Dates

The next estimated earnings date is Friday, March 28, 2025.

Earnings Date Mar 28, 2025
Ex-Dividend Date n/a

Share Statistics

EMED has 930.03 million shares outstanding. The number of shares has increased by 78.66% in one year.

Current Share Class n/a
Shares Outstanding 930.03M
Shares Change (YoY) +78.66%
Shares Change (QoQ) -64.96%
Owned by Insiders (%) 1.71%
Owned by Institutions (%) n/a
Float 914.12M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.12
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -1.53
EV / Sales 2.79
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.07

Current Ratio 0.07
Quick Ratio 0.01
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -4.38

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -88.83%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 26.69%
Revenue Per Employee 153,668
Profits Per Employee -280,300
Employee Count 6
Asset Turnover 1.30
Inventory Turnover 2.95

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -69.23% in the last 52 weeks. The beta is 1.44, so EMED's price volatility has been higher than the market average.

Beta (5Y) 1.44
52-Week Price Change -69.23%
50-Day Moving Average 0.00
200-Day Moving Average 0.00
Relative Strength Index (RSI) 47.12
Average Volume (20 Days) 12,282,805

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.01

Income Statement

In the last 12 months, EMED had revenue of 922,010 and -1.68 million in losses. Loss per share was -0.00.

Revenue 922,010
Gross Profit 692,231
Operating Income -1.01M
Pretax Income -1.68M
Net Income -1.68M
EBITDA -1.01M
EBIT -1.01M
Loss Per Share -0.00
Full Income Statement

Balance Sheet

The company has 34,809 in cash and 1.66 million in debt, giving a net cash position of -1.63 million or -0.00 per share.

Cash & Cash Equivalents 34,809
Total Debt 1.66M
Net Cash -1.63M
Net Cash Per Share -0.00
Equity (Book Value) -4.00M
Book Value Per Share -0.01
Working Capital -4.05M
Full Balance Sheet

Cash Flow

Operating Cash Flow -131,211
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 75.08%, with operating and profit margins of -109.62% and -182.03%.

Gross Margin 75.08%
Operating Margin -109.62%
Pretax Margin -182.03%
Profit Margin -182.03%
EBITDA Margin -109.25%
EBIT Margin -109.62%
FCF Margin n/a

Dividends & Yields

EMED does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -78.66%
Shareholder Yield -78.66%
Earnings Yield -904.17%
FCF Yield n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

EMED has an Altman Z-Score of -83.62. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -83.62
Piotroski F-Score n/a